Sivik Global Healthcare LLC Buys Novo Nordisk A/S, Alexion Pharmaceuticals Inc, Sanofi SA, Sells Cigna Corp, UnitedHealth Group Inc, SPDR Series Trust S&P Biotech

• New Purchases: NVO, ALXN, SNY, CELG, LH, ABBV, NVRO, EW, CHRS, BLUE, XRAY, VAR, FMS, BPMC, PRGO, PBYI, AKRX, SGEN,
• Added Positions: GWPH, BAX, MOH, HCA, ELAN, MYL, HUM, BIO, INCY, DHR, LLY, ANTM, TMO, SNN, BHC, REGN, CNC, AGIO, WCG, UHS, AZN, DXCM, TEVA, WMGI, BSX,
• Reduced Positions: ISRG, BIIB, ABT, QGEN, BMRN, VRTX, SYK, ILMN, SRPT, LHCG, A,
• Sold Out: CI, UNH, XBI, ZBH, MCK, LOXO, ABC, HAE,

For the details of Sivik Global Healthcare LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sivik+global+healthcare+llc/current-portfolio/portfolio

1. WellCare Health Plans Inc (WCG) - 35,000 shares, 3.48% of the total portfolio. Shares added by 7.69%
2. Eli Lilly and Co (LLY) - 70,000 shares, 3.35% of the total portfolio. Shares added by 27.27%
3. Boston Scientific Corp (BSX) - 225,000 shares, 3.19% of the total portfolio. Shares added by 2.27%
4. Baxter International Inc (BAX) - 105,000 shares, 3.15% of the total portfolio. Shares added by 75.00%
5. Abbott Laboratories (ABT) - 100,000 shares, 2.95% of the total portfolio. Shares reduced by 13.04%

Sivik Global Healthcare LLC initiated holding in Novo Nordisk A/S. The purchase prices were between $46.07 and $52.63, with an estimated average price of $49.1. The stock is now traded at around $48.56. The impact to a portfolio due to this purchase was 2.61%. The holding were 135,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $97.36 and $137.75, with an estimated average price of $123.89. The stock is now traded at around $133.71. The impact to a portfolio due to this purchase was 2.24%. The holding were 45,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Sanofi SA. The purchase prices were between $40.83 and $45.43, with an estimated average price of $42.82. The stock is now traded at around $41.14. The impact to a portfolio due to this purchase was 2.12%. The holding were 130,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Celgene Corp. The purchase prices were between $64.09 and $94.34, with an estimated average price of $87.12. The stock is now traded at around $95.77. The impact to a portfolio due to this purchase was 2.09%. The holding were 60,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $123.7 and $156.3, with an estimated average price of $143.14. The stock is now traded at around $163.51. The impact to a portfolio due to this purchase was 1.41%. The holding were 25,000 shares as of .

Sivik Global Healthcare LLC initiated holding in AbbVie Inc. The purchase prices were between $77.14 and $92.19, with an estimated average price of $82.08. The stock is now traded at around $78.40. The impact to a portfolio due to this purchase was 1.26%. The holding were 42,500 shares as of .

Sivik Global Healthcare LLC added to a holding in GW Pharmaceuticals PLC by 500.00%. The purchase prices were between $97.39 and $177.34, with an estimated average price of $147.85. The stock is now traded at around $185.49. The impact to a portfolio due to this purchase was 1.56%. The holding were 30,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Baxter International Inc by 75.00%. The purchase prices were between $64.48 and $81.31, with an estimated average price of $72.66. The stock is now traded at around $77.06. The impact to a portfolio due to this purchase was 1.35%. The holding were 105,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Molina Healthcare Inc by 83.33%. The purchase prices were between $105.9 and $148.29, with an estimated average price of $134.96. The stock is now traded at around $129.46. The impact to a portfolio due to this purchase was 1.31%. The holding were 55,000 shares as of .

Sivik Global Healthcare LLC added to a holding in HCA Healthcare Inc by 71.43%. The purchase prices were between $119.44 and $144.26, with an estimated average price of $134.31. The stock is now traded at around $125.09. The impact to a portfolio due to this purchase was 1.2%. The holding were 60,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Elanco Animal Health Inc by 109.24%. The purchase prices were between $29 and $32.83, with an estimated average price of $30.78. The stock is now traded at around $31.39. The impact to a portfolio due to this purchase was 1.08%. The holding were 175,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Mylan NV by 166.97%. The purchase prices were between $26.01 and $32.1, with an estimated average price of $29.18. The stock is now traded at around $21.99. The impact to a portfolio due to this purchase was 0.98%. The holding were 150,000 shares as of .

Sivik Global Healthcare LLC sold out a holding in Cigna Corp. The sale prices were between $159.69 and $199.81, with an estimated average price of $183.17.

Sivik Global Healthcare LLC sold out a holding in UnitedHealth Group Inc. The sale prices were between $236.02 and $271.13, with an estimated average price of $255.35.

Sivik Global Healthcare LLC sold out a holding in SPDR Series Trust S&P Biotech. The sale prices were between $71.21 and $91.92, with an estimated average price of $84.86.

Sivik Global Healthcare LLC sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $100.43 and $129.56, with an estimated average price of $116.76.

Sivik Global Healthcare LLC sold out a holding in McKesson Corp. The sale prices were between $110.47 and $136.3, with an estimated average price of $123.47.

Sivik Global Healthcare LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $131.02 and $234.75, with an estimated average price of $222.49.